S H Kelkar And Company Ltd · NSE:SHK
S H Kelkar And — Q4 FY2021 Earnings Presentation
24 slides from S H Kelkar And's earnings presentation, May 27, 2021
Slide 1: Cover letter to stock exchanges
Keva March 27, 2021 To To The Manager The Manager The Department of Corporate Services The Listing Department BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai — 400 001 Bandra (East), Mumbai — 400 051 Scrip Code:
Slide 2: S H Kelkar announces Q4 & FY2021 results
Keva ‘ "A S H Kelkar and Company Limited Corporate Office: L.B.S Marg, Near Balrajeshwar Temple, Mulund (W), Mumbai — 400080 Registered Office: Devkaran Mansion, 36, Mangaldas Road, Mumbai 400 002. S H Kelkar announces Q4 & FY2021 results FY2021 Revenues from operations** at Rs. 1,315.1 cr EBITDA**
Slide 3: Commenting on the performance
te e FY21 PAT includes exceptional income of Rs. 12.5 crore on account of re-measurement of stake in CFF after it was recognised as a wholly owned subsidiary of SHK. The impairment of plants and machineries in Netherlands resulted in a one-time exceptional expense of Rs. 36.5 crore, which impacted r
Slide 4: Announces dividend of Re. 0.75 per share
te Exclusive distributor for Isobionics Santalol in India SH Kelkar has become the exclusive distributor for Isobionics Santalol in India The new fragrance ingredient is the first joint product from BASF and Isobionics and is now available for the Indian market through SHK The new fragrance ingredie
Slide 5: About S H Kelkar and Company Limited
Keva About S H Kelkar and Company Limited: S H Kelkar and Company Limited (SHK) is the largest Indian-origin Fragrance & Flavour Company in India. It has a long standing reputation in the fragrance industry developed in 96 years of experience. Its fragrance products and ingredients are used as a raw
Slide 6: S H Kelkar and Company Limited Q4 & FY21
S H KELKAR AND COMPANY LIMITED Q4 & FY21 Earnings Presentation May 27, 2021
Slide 7: Disclaimer
Disclaimer Certain statements and opinions with respect to the anticipated future performance of SH Kelkar (SHK) in the presentation (“forward-looking statements”), which reflect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to be correct. Suc
Slide 8: Q4 & FY21 Results Overview
eAny IUNUDIIS Q4 & FY21 Results Overview
Slide 9: Management Comment
Management Comment Commenting on the performance, Mr. Kedar Vaze, Whole Time Director & CEO at SH Kelkar and Company Ltd. said: “We are pleased to share that we have delivered a healthy performance driven by normalization in demand and enquiries across both domestic and international markets. The qu
Slide 10: Consolidated Summarized P&L Statement
Consolidated Summarized P&L Statement Y-o-Y Y-o-Y Particulars (Rs. crore) Q4 FY21 Q4 FY20 FY21 FY20 Change (%) Change (%) Revenue from Operations 396.5 269.8 47.0% 1,315.1 1,105.1 19.0% Sales 376.0 269.8 39.4% 1,260.0 1,105.1 14.0% Sales - Contract Manufacturing 20.5 - - 55.1 - - Other Operating Inc
Slide 11: Consolidated Balance Sheet
Consolidated Balance Sheet EQUITY AND LIABILITIES CONSOLIDATED CONSOLIDATED ASSETS CONSOLIDATED CONSOLIDATED As at 31st March 2021 As at 31st March 2020 As at 31st March 2021 As at 31st March 2020 Particulars (Rs. Crore) Particulars (Rs. Crore) (Audited) (Audited) (Audited) (Audited) Equity ASSETS E
Slide 12: Key Developments
Key Developments Acquisition of Nova Fragranze S.r.l. (Nova) SH Kelkar’s wholly-owned subsidiaries - Keva Italy and CFF - entered into an agreement for acquisition of 70% equity stake of Nova − The acquisition has been completed and is effective from April 01, 2021 Incorporated in the year 1992,
Slide 13: Key Developments
Key Developments Exclusive distributor for Isobionics Santalol in India SH Kelkar has become the exclusive distributor for Isobionics Santalol in India The new fragrance ingredient is the first joint product from BASF and Isobionics and is now available for the Indian market through SHK The ne
Slide 14: Financial and Operational Discussions (Y-o-Y)
Financial and Operational Discussions (Y-o-Y) Q4 FY21 Revenues from operations stood at Rs. 396.5 crore, higher by 47.0% Y-o-Y; FY21 Revenues from operations up 19.0% Y-o-Y to Rs. 1,315.1 crore During the quarter, the Company witnessed normalization in demand and enquiries in domestic and internat
Slide 15: Fragrance Division
Fragrance Division The Company saw improved wins from existing and new large and mid-sized FMCG customers in the domestic markets Q4 Q4 Y-o-Y Y-o-Y Particulars (Rs. crore) FY21 FY20 In addition, normalisation in demand across FY21 FY20 (%) (%) domestic and international markets assisted 363.5 24
Slide 16: Flavour Division
Flavour Division The segment witnessed steady offtake in domestic and European markets during the Q4 Q4 Y-o-Y Y-o-Y quarter Particulars (Rs. crore) FY21 FY20 Margins during the year remained at healthy FY21 FY20 (%) (%) levels Revenues from Operations 33.0 29.7 11.2% 111.8 107.0 4.5% While mar
Slide 17: CFF Performance
CFF Performance CFF – Abridged P&L Statement CFF delivered a robust performance on the Quarter ending back of increasing demand and volume off- Particulars as a % of Sales March 31, 2021 take in the Italian and other European Sales – Core Fragrance 47.0 markets Sales – Contract Manufacturing 20.5
Slide 18: Balance Sheet Snapshot – As on March 31, 2021
Balance Sheet Snapshot – As on March 31, 2021 955 797 139 380 Networth Fixed Assets Cash & Net Debt* Investments Note: 1) *The Company’s net debt position includes consolidation of CFF debt and payment of the second and final tranche of the CFF acquisition of ~Rs. 141 crore 2) All Figures in Rs. cro
Slide 19: Cash Flow Snapshot
Cash Flow Snapshot Particulars (Rs. crore) FY17 FY18 FY19 FY20 FY21 Net Cash flows from operating activities 102 103 77 205 195 Net Cash flow from investing activities -96 -221 -137 -40 -149 Net 6 -117 -60 165 46 Note: Cash Note: Cashand andcash equivalent cash includes equivalent investments includ
Slide 20: Key Financial Ratios
Key Financial Ratios Particulars (Rs. crore) FY17 FY18 FY19 FY20 FY21 EBITDA margin (%) 17.9 18.0 14.9 14.8 19.3 PAT Margin (%) 10.6 8.8 8.2 6.3 9.8 Debt to Equity 0.1 0.2 0.4 0.4 0.4 Return on Networth (%) 14.3 13.8 12.0 10.0 17.9 Return on Capital Employed (%) 22.7 20.2 13.5 11.3 17.2 Note: 1. Ret
Slide 21: Annexure
Annexure 16
Slide 22: Conference Call Details
Conference Call Details S H Kelkar and Company – Q4 & FY21 Earnings Conference Call Time • 02:00 PM IST on Friday, May 28, 2021 Primary dial-in number • +91 22 6280 1141 • +91 22 7115 8042 India Local access Number • +91 70456 71221 (Available all over India) • Hong Kong: 800 964 448 International T
Slide 23: About Us
About Us S H Kelkar and Company Limited (SHK) is the largest Indian-origin Fragrance & Flavour For further information please contact: Company in India. It has a long standing reputation in the fragrance industry developed in 96 years of experience. Its fragrance products and ingredients are used as
Slide 24: 19
19
S H Kelkar and Company — Q4 FY2021 Earnings Presentation on 6ix